Journal Top Ten -- Columns-Drugs & Supplements -- December 2003
December 23, 2003
1 Related Drug: Avandia
photo-1Article: Rosiglitazone Activates Renal Sodium- and Water-Reabsorptive Pathways and Lowers Blood Pressure in Normal Rats
Summary: The article describes the results of a study designed to test whether rosiglitazone (Avandia, GSK) may be associated with fluid retention and edema by activating sodium and water reabsorptive processes in the kidney, possibly as a response to a drop in arterial blood pressure. Researchers administered rosiglitazone (47 or 94 mg/kg diet) to male Sprague-Dawley rats for three days and measure the mean arterial blood pressure. The article stated that the mean arterial blood pressure decreased significantly …
UPCOMING CONFERENCES
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach